Bodor N (1984) Novel approaches to the design of safer drugs: soft drugs and chemical deliver systems. In: Testa B (ed) Advances in drug research. Academic Press, Orlando, pp 255–331
Google Scholar
Boyd MR (1997) In: Teicher BA (ed) Cancer drug discovery and development. Humana Press, Totowa, pp 23–43
Boyd MR, Paull KD (1995) Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen. Drug Dev Res 34:91–109
Article
CAS
Google Scholar
Brier S, Lemaire D, Debonis S, Forest E, Kozielski F (2004) Identification of the protein binding region of S-trityl-l-cysteine, a new potent inhibitor of the mitotic kinesin Eg5. Biochem 43:13072–13082
Article
CAS
Google Scholar
Chen J, Liu J, Zhang L, Wu G, Hua W, Wu X, Suna H (2006) Pentacyclic triterpenes. Part 3: synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase. Bioorg Med Chem Lett 16:2915–2919
PubMed
Article
CAS
Google Scholar
Cichewicz RH, Kouzi SA (2004) Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med Res Rev 24:90–114
PubMed
Article
CAS
Google Scholar
Couch RD, Browning RG, Honda T, Gribble GW, Wright DL, Sporn MB, Anderson AC (2005) Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action. Bioorg Med Chem Lett 15:2215–2219
PubMed
Article
CAS
Google Scholar
Cutshall NS, O’Day C, Prezhdo M (2005) Rhodanine derivatives as inhibitors of JSP-1. Bioorg Med Chem Lett 15:3374–3379
PubMed
Article
CAS
Google Scholar
Deghengni R, Daneault G (1960) Orotic acid and its analogues: part II. On the alkaline rearrangement of 5-carboxymethylidenehydantoin. Can J Chem 38:1255–1260
Article
Google Scholar
Degterev A, Lugovskoy A, Cardone M, Mulley B, Wagner G, Mitchison T, Yuan J (2001) Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xl. Nat Cell Biol 3:173–182
PubMed
Article
CAS
Google Scholar
Dinkova-Kostova AT, Liby KT, Stephenson KK, Holtzclaw WD, Gao X, Suh N, Williams C, Risingsong R, Honda T, Gribble GW, Sporn MB, Talalay P (2005) Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress. PNAS 102:4584–4589
PubMed
Article
CAS
Google Scholar
Finlay HJ, Honda T, Gribble GW (2002) Synthesis of novel [3, 2-b]indole fused oleanolic acids as potential inhibitors of cell proliferation. ARKIVOC XII:38–46
Google Scholar
Han SK, Ko YI, Park SJ, Jin IJ, Kim YM (1997) Oleanolic acid and ursolic acid stabilize liposomal membranes. Lipids 32:769–773
PubMed
Article
CAS
Google Scholar
Havrylyuk D, Zimenkovsky B, Vasylenko O, Zaprutko L, Gzella A, Lesyk R (2009) Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. Eur J Med Chem 44:1396–1404
PubMed
Article
CAS
Google Scholar
Hollingshead MG, Alley MC, Camalier RF, Abbott BJ, Mayo JG, Malspeis L, Grever MR (1995) In vivo cultivation of tumor cells in hollow fibers. Life Sci 57:131–141
PubMed
Article
CAS
Google Scholar
Honda T, Gribble GW, Suh N, Finlay HJ, Rounds BV, Bore L, Favaloro FG Jr, Wang Y, Sporn MB (2000a) Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages. J Med Chem 43:1866–1877
PubMed
Article
CAS
Google Scholar
Honda T, Rounds BV, Bore L, Finlay HJ, Favaloro FG Jr, Suh N, Wang Y, Sporn MB, Gribble GW (2000b) Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophages. J Med Chem 43:4233–4246
PubMed
Article
CAS
Google Scholar
Kaminskyy DV, Lesyk RB (2010) Structure-anticancer activity relationships among 4-azolidinone-3-carboxylic acids derivatives. Biopolym Cell 26:136–145
CAS
Google Scholar
Kaminskyy D, Zimenkovsky B, Lesyk R (2009) Synthesis and in vitro anticancer activity of 2,4-azolidinedione-acetic acids derivatives. Eur J Med Chem 44:3627–3636
PubMed
Article
CAS
Google Scholar
Konoki MHK, Tachibana K (1996) Cholesterol-independent membrane disruption caused by triterpenoid saponins. Biochim Biophys Acta 1299:252–258
PubMed
Article
Google Scholar
Lee J, Kim J, Koh JS, Chung HH, Kim KH (2006) Hydantoin derivatives as non-peptidic inhibitors of Ras farnesyl transferase. Bioorg Med Chem Lett 16:1954–1956
PubMed
Article
CAS
Google Scholar
Lesyk RB, Zimenkovsky BS (2004) 4-Thiazolidones: centenarian history, current status and perspectives for modern organic and medicinal chemistry. Curr Org Chem 8:1547–1578
Article
CAS
Google Scholar
Lesyk R, Zimenkovsky B, Troc’ko N, Kazmirchuk G (2002) Synthesis of 5-arylidene-2,4-thiazolidin-3-yl alkanoic acids. Annal UMCS Sec DDD 15:39–45
Google Scholar
Lesyk R, Zimenkovsky B, Kaminskyy D, Holota S, Atamanyuk D, Havrylyuk D, Nektegaev I, Kazmirchuk G, Subtel’na I, Roman O, Kryshchyshyn A, Khyluk D (2006) Anticancer potential of 4-azolidones and related heterocycles. Annal UMCS Sec DDD 19:107–110
Google Scholar
Lewis KG, Tucker DJ (1983) The separation of substituted olean-12-en-28-oic acid from the corresponding Urs-12-en-28-oic acid isomers. Aust J Chem 36:2297–2305
Article
CAS
Google Scholar
Liby KT, Yore MM, Sporn MB (2007) Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat Rev Cancer 7:357–369
PubMed
Article
CAS
Google Scholar
Liu J (2005) Oleanolic acid and ursolic acid: research perspectives. J Ethnopharmacol 100:92–94
PubMed
Article
CAS
Google Scholar
Ma C, Nakamura N, Hattori M (2000) Chemical modification of oleanene type triterpenes and their inhibitor activity against HIV-1 protease dimerization. Chem Pharm Bull (Tokoyo) 48:1681–1688
Article
CAS
Google Scholar
Ma C, Nakamura N, Hattori M, Kawahata T, Otake T (2002) Inhibitory Effects of triterpene–azidothymidine conjugates on proliferation of human immunodeficiency virus type 1 and its protease. Chem Pharm Bull (Tokoyo) 50:877–880
Article
CAS
Google Scholar
Mallarno JP, Pilling GM, Wetzel JR, Kowalczyk PJ, Bell MR, Kullnig RK, Batzold FH, Juniewicz PE, Winneker RC, Luss HR (1992) Anti-androgenic steroidal sulfonyl heterocycles. Utility of electrostatic complementarity in defining bioisosteric sulfonyl heterocycles. J Med Chem 35:1663–1670
Article
Google Scholar
Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Nat Cancer Inst 83:757–766
PubMed
Article
CAS
Google Scholar
Nair KG, Moayeri H, Mittelman A (1980) A phase II study of fluorodopan in the treatment of advanced colorectal cancer. Cancer Treat Rep 64:697–699
PubMed
CAS
Google Scholar
Plowman J, Dykes DJ, Hollingshead M, Simpson-Herren L, Alley MC (1997) Human tumor xenograft models in NCI drug development. In: Teicher B (ed) Anticancer drug development guide: preclinical screening, clinical trials, and approval. Humana Press, Totowa, pp 101–125
Google Scholar
Popov-Pergal K, Rancic M, Pergal M, Bogdanovic G, Kojic V, Djokovic D (2006) Synthesis and biological activity evaluation of new functionally substituted 5-arylidene-2,4-dioxotetrahydro-1,3-thiazoles. J Serb Chem Soc 71:61–866
Article
Google Scholar
Shirane N, Hashimoto Y, Ueda K, Takenaka H, Katoh K (1996) Ring-A cleavage of 3-oxo-olean-12-en-28-oic acid by the fungus chaetomium longirostre. Phytochem 43:99–104
Article
CAS
Google Scholar
Shoemaker RH (2006) The NCI 60 human tumour cell line anticancer drug screen. Nat Rev Cancer 6:813–823
PubMed
Article
CAS
Google Scholar
Simonsen J, Rossk WCI (1957) The terpenes. Volume 5: the triterpenes and their derivatives. University Press, Cambridge
Google Scholar
Subtel’na I, Atamanyuk D, Szymańska E, Kieć-Kononowicz K, Zimenkovsky B, Vasylenko O, Gzella A, Lesyk R (2010) Synthesis of 5-arylidene-2-amino-4-azolones and evaluation of their anticancer activity. Bioorg Med Chem 18:5090–5102
PubMed
Article
Google Scholar
Teng X, Degterev A, Jagtap P, Xing X, Choi S, Denu R, Yuan J, Cuny GD (2005) Structure-activity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett 15:5039–5044
PubMed
Article
CAS
Google Scholar
Yakubych VY, Fedirko YaM (1983) Synthesis and properties of rhodanines synthesized base on aspartic acid. Farmacevtychnyj Zhurn (Kyiv) 5:58–60 In Ukrainian
Google Scholar
Yasue M, Sakakibara J, Kaiya T (1974) Syntheses of nitrogen-containing triterpenes. III Derivatives of betulinic acid and oleanolic acid. J Pharm Soc Jpn 94:1468–1474
CAS
Google Scholar
Zaharevitz DW, Holbeck SL, Bowerman C, Svetlik PA (2002) COMPARE: a web accessible tool for investigating mechanisms of cell growth inhibition. J Mol Graphics Model 20:297–303
Article
CAS
Google Scholar
Zaprutko L, Partyka D, Bednarczyk-Cwynar B (2004) Triterpenoids. Part 21. Olenolic acid azaderivatives as perculatenous transport promoters. Bioorg Med Chem Lett 14:4723–4726
PubMed
Article
CAS
Google Scholar
Zimenkovsky B, Kutsyk R, Lesyk R, Matiychuk V, Obushak N, Klyufinska T (2006) Synthesis and antimicrobial activity of 2,4-dioxothiazolidine-5-acetic acid amides. Pharm Chem J 40:303–306
Article
Google Scholar